Nikolaj Kunøe

1.1k total citations
32 papers, 746 citations indexed

About

Nikolaj Kunøe is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Nikolaj Kunøe has authored 32 papers receiving a total of 746 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Public Health, Environmental and Occupational Health, 20 papers in Epidemiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Nikolaj Kunøe's work include Opioid Use Disorder Treatment (24 papers), Substance Abuse Treatment and Outcomes (20 papers) and Prenatal Substance Exposure Effects (6 papers). Nikolaj Kunøe is often cited by papers focused on Opioid Use Disorder Treatment (24 papers), Substance Abuse Treatment and Outcomes (20 papers) and Prenatal Substance Exposure Effects (6 papers). Nikolaj Kunøe collaborates with scholars based in Norway, United Kingdom and United States. Nikolaj Kunøe's co-authors include Philipp Lobmaier, Lars Tanum, Arild Opheim, Kristin Klemmetsby Solli, Zill-E-Huma Latif, Jūratė Šaltytė Benth, Helge Waal, Peter Krajči, Michael Gossop and Arild Bjørndal and has published in prestigious journals such as Biological Psychiatry, Cochrane Database of Systematic Reviews and Neuropsychopharmacology.

In The Last Decade

Nikolaj Kunøe

31 papers receiving 726 citations

Peers

Nikolaj Kunøe
Philipp Lobmaier Norway
Ayman Fareed United States
Johan Kakko Sweden
Harald Eder Austria
Edwin A. Salsitz United States
Eric Wargo United States
Shanthi Mogali United States
Jennifer Casarella United States
Annie Mino Switzerland
Katharina Wiest United States
Philipp Lobmaier Norway
Nikolaj Kunøe
Citations per year, relative to Nikolaj Kunøe Nikolaj Kunøe (= 1×) peers Philipp Lobmaier

Countries citing papers authored by Nikolaj Kunøe

Since Specialization
Citations

This map shows the geographic impact of Nikolaj Kunøe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaj Kunøe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaj Kunøe more than expected).

Fields of papers citing papers by Nikolaj Kunøe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolaj Kunøe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaj Kunøe. The network helps show where Nikolaj Kunøe may publish in the future.

Co-authorship network of co-authors of Nikolaj Kunøe

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolaj Kunøe. A scholar is included among the top collaborators of Nikolaj Kunøe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolaj Kunøe. Nikolaj Kunøe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solli, Kristin Klemmetsby, et al.. (2025). Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individuals. Contemporary Clinical Trials. 152. 107861–107861.
2.
Indregard, Anne-Marthe Rustad, et al.. (2024). Open-door policy versus treatment-as-usual in urban psychiatric inpatient wards: a pragmatic, randomised controlled, non-inferiority trial in Norway. The Lancet Psychiatry. 11(5). 330–338. 4 indexed citations
3.
Opheim, Arild, Jūratė Šaltytė Benth, Kristin Klemmetsby Solli, et al.. (2023). Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial. Contemporary Clinical Trials. 135. 107360–107360. 2 indexed citations
4.
5.
Opheim, Arild, Jūratė Šaltytė Benth, Kristin Klemmetsby Solli, et al.. (2022). Risk of Relapse to Non-Opioid Addictive Substances Among Opioid Dependent Patients Treated with an Opioid Receptor Antagonist or a Partial Agonist: A Randomized Clinical Trial. SSRN Electronic Journal. 1 indexed citations
6.
Fadnes, Lars Thore, Jūratė Šaltytė Benth, Kristin Klemmetsby Solli, et al.. (2021). The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse. European Addiction Research. 28(1). 56–67. 5 indexed citations
7.
Opheim, Arild, Kristin Klemmetsby Solli, Zill-E-Huma Latif, et al.. (2021). Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial. American Journal on Addictions. 30(5). 453–460. 4 indexed citations
8.
Eikemo, Marie, Philipp Lobmaier, Mads L. Pedersen, et al.. (2019). Intact responses to non-drug rewards in long-term opioid maintenance treatment. Neuropsychopharmacology. 44(8). 1456–1463. 12 indexed citations
9.
Solli, Kristin Klemmetsby, Nikolaj Kunøe, Zill-E-Huma Latif, et al.. (2019). Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial. European Addiction Research. 25(6). 303–309. 9 indexed citations
10.
Tanum, Lars, Kristin Klemmetsby Solli, Zill-E-Huma Latif, et al.. (2017). Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence. JAMA Psychiatry. 74(12). 1197–1197. 178 indexed citations
11.
12.
Kunøe, Nikolaj, et al.. (2016). Interest in Extended Release Naltrexone among Opioid Users. European Addiction Research. 22(6). 301–305. 6 indexed citations
13.
Kunøe, Nikolaj, et al.. (2016). Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX). BMC Pharmacology and Toxicology. 17(1). 18–18. 22 indexed citations
14.
Kunøe, Nikolaj, Philipp Lobmaier, John‐Kåre Vederhus, et al.. (2010). Retention in naltrexone implant treatment for opioid dependence. Drug and Alcohol Dependence. 111(1-2). 166–169. 17 indexed citations
15.
Lobmaier, Philipp, Nikolaj Kunøe, Michael Gossop, & Helge Waal. (2010). Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review. CNS Neuroscience & Therapeutics. 17(6). 629–636. 50 indexed citations
16.
Kunøe, Nikolaj, Philipp Lobmaier, John‐Kåre Vederhus, et al.. (2010). Challenges to antagonist blockade during sustained‐release naltrexone treatment. Addiction. 105(9). 1633–1639. 17 indexed citations
17.
Lobmaier, Philipp, Nikolaj Kunøe, & Helge Waal. (2010). Treatment research in prison: Problems and solutions in a randomized trial. Addiction Research & Theory. 18(1). 1–13. 21 indexed citations
18.
Hegstad, Solfrid, Hassan Z. Khiabani, Lena Kristoffersen, et al.. (2008). Drug Screening of Hair by Liquid Chromatography-Tandem Mass Spectrometry. Journal of Analytical Toxicology. 32(5). 364–372. 77 indexed citations
19.
Lobmaier, Philipp, Hege Kornør, Nikolaj Kunøe, & Arild Bjørndal. (2008). Sustained-Release Naltrexone For Opioid Dependence. Cochrane Database of Systematic Reviews. CD006140–CD006140. 82 indexed citations
20.
Kunøe, Nikolaj & Sidsel Graff‐Iversen. (2002). [Smoking as a theme in popular health literature 1940-1960].. PubMed. 122(3). 306–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipp Lobmaier Breakdown of academic impact, for papers by Ayman Fareed Breakdown of academic impact, for papers by Johan Kakko Breakdown of academic impact, for papers by Harald Eder Breakdown of academic impact, for papers by Edwin A. Salsitz Breakdown of academic impact, for papers by Eric Wargo Breakdown of academic impact, for papers by Shanthi Mogali Breakdown of academic impact, for papers by Jennifer Casarella Breakdown of academic impact, for papers by Annie Mino Breakdown of academic impact, for papers by Katharina Wiest
Rankless by CCL
2026